Utilization of a right-handed coiled-coil protein from archaebacterium Staphylothermus marinus as a carrier for cisplatin.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 19331128)

Published in Anticancer Res on January 01, 2009

Authors

Mathilda Eriksson1, Saadia Hassan, Rolf Larsson, Stig Linder, Torbjörn Ramqvist, Henrik Lövborg, Trine Vikinge, Egbert Figgemeier, Jürgen Müller, Jörg Stetefeld, Tina Dalianis, Suat Ozbek

Author Affiliations

1: Karolinska Institutet, Department of Oncology-Pathology, Cancer Center Karolinska R8:01, Karolinska University Hospital, 171 76 Stockholm.

Articles by these authors

Identification of a third human polyomavirus. J Virol (2007) 7.06

Regulation of Raf-1 by direct feedback phosphorylation. Mol Cell (2005) 5.88

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer (2009) 4.50

Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat Med (2011) 4.09

The dynamic genome of Hydra. Nature (2010) 4.00

Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer (2006) 3.38

Tumour class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res (2002) 2.34

Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol (2007) 2.27

Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J Biol Chem (2002) 2.20

Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res (2004) 2.03

Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis (2010) 1.85

Continuous molecular evolution of protein-domain structures by single amino acid changes. Curr Biol (2007) 1.81

The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer (2010) 1.69

Proteolytic E-cadherin activation followed by solution NMR and X-ray crystallography. EMBO J (2004) 1.69

Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA. Int J Cancer (2007) 1.67

Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer (2002) 1.66

Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias. J Biol Chem (2004) 1.65

Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol (2013) 1.57

Syntaxin 11 is required for NK and CD8⁺ T-cell cytotoxicity and neutrophil degranulation. Eur J Immunol (2012) 1.57

Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir. Int J Cancer (2008) 1.55

Calpain-mediated Bid cleavage and calpain-independent Bak modulation: two separate pathways in cisplatin-induced apoptosis. Mol Cell Biol (2002) 1.54

Multiple Wnts are involved in Hydra organizer formation and regeneration. Dev Biol (2009) 1.54

Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes (2002) 1.52

ERK5: structure, regulation and function. Cell Signal (2012) 1.50

The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol (2007) 1.49

A novel high-through-put assay for screening of pro-apoptotic drugs. Invest New Drugs (2002) 1.49

The mutational landscape in pediatric acute lymphoblastic leukemia deciphered by whole genome sequencing. Hum Mutat (2015) 1.46

Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy. Clin Cancer Res (2007) 1.45

Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface. J Thorac Cardiovasc Surg (2002) 1.44

Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci U S A (2004) 1.42

Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer (2004) 1.40

[Human papillomavirus important factor in the increased incidence of tonsillar cancer]. Lakartidningen (2006) 1.40

A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance. Blood (2013) 1.38

KI, WU and Merkel cell polyomaviruses: a new era for human polyomavirus research. Semin Cancer Biol (2009) 1.37

Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells. Nucleic Acids Res (2007) 1.36

The fluorometric microculture cytotoxicity assay. Nat Protoc (2008) 1.36

Electronic energy transfer and collection in luminescent molecular rods containing ruthenium(II) and osmium(II) 2,2':6',2"-terpyridine complexes linked by thiophene-2,5-diyl spacers. Chemistry (2002) 1.35

Nanosecond-scale kinetics of nematocyst discharge. Curr Biol (2006) 1.34

Cyclotides: a novel type of cytotoxic agents. Mol Cancer Ther (2002) 1.32

Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. J Med Chem (2008) 1.32

Aminopeptidase N (CD13) as a target for cancer chemotherapy. Cancer Sci (2011) 1.30

Molecular classification of borderline ovarian tumors using hierarchical cluster analysis of protein expression profiles. Int J Cancer (2002) 1.30

Evolution of complex structures: minicollagens shape the cnidarian nematocyst. Trends Genet (2008) 1.29

Processing of pulmonary surfactant protein B by napsin and cathepsin H. J Biol Chem (2004) 1.29

Tracking down the different forms of nuclear actin. Trends Cell Biol (2006) 1.29

An epidemic of oropharyngeal squamous cell carcinoma (OSCC) due to human papillomavirus (HPV) infection and aspects of treatment and prevention. Anticancer Res (2011) 1.27

Characterization of the cytotoxic properties of the benzimidazole fungicides, benomyl and carbendazim, in human tumour cell lines and primary cultures of patient tumour cells. Anticancer Drugs (2010) 1.25

Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease. Blood (2012) 1.25

Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes (2007) 1.24

Wnt/beta-catenin and noncanonical Wnt signaling interact in tissue evagination in the simple eumetazoan Hydra. Proc Natl Acad Sci U S A (2009) 1.23

P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. Anticancer Res (2005) 1.22

Nucleation and propagation of the collagen triple helix in single-chain and trimerized peptides: transition from third to first order kinetics. J Mol Biol (2002) 1.21

Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS One (2012) 1.21

Concentration and distribution of heavy metals in urban airborne particulate matter in Frankfurt am Main, Germany. Environ Sci Technol (2005) 1.20

Optimal heparin surface concentration and antithrombin binding capacity as evaluated with human non-anticoagulated blood in vitro. J Biomed Mater Res A (2003) 1.19

Cytotoxic cyclotides from Viola tricolor. J Nat Prod (2004) 1.18

Selective cytotoxicity evaluation in anticancer drug screening of fractionated plant extracts. J Biomol Screen (2002) 1.18

Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors. Int J Cancer (2003) 1.17

Substitutions in woolly mammoth hemoglobin confer biochemical properties adaptive for cold tolerance. Nat Genet (2010) 1.17

Autophagy is a protective mechanism for human melanoma cells under acidic stress. J Biol Chem (2012) 1.17

Human papillomavirus and survival in patients with base of tongue cancer. Int J Cancer (2010) 1.16

The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Haematologica (2006) 1.15

Characterisation of Drosophila thrombospondin defines an early origin of pentameric thrombospondins. J Mol Biol (2003) 1.15

C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase. J Immunol (2002) 1.13

Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo. Int J Cancer (2012) 1.13

Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients. Biochem Pharmacol (2006) 1.12

Large-scale proteomics analysis of human ovarian cancer for biomarkers. J Proteome Res (2007) 1.12

The levels of caspase-cleaved cytokeratin 18 are elevated in serum from patients with lung cancer and helpful to predict the survival. Lung Cancer (2007) 1.11

Antimicrobial and cytotoxic activity of agelasine and agelasimine analogs. Bioorg Med Chem (2007) 1.11

Proteome of Hydra nematocyst. J Biol Chem (2012) 1.11

Vimentin coil 1A-A molecular switch involved in the initiation of filament elongation. J Mol Biol (2009) 1.10

High content screening for inhibitors of protein interactions and post-translational modifications in primary cells by proximity ligation. Mol Cell Proteomics (2009) 1.10

STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines. Int J Cancer (2007) 1.09

Loss of cell membrane integrity in puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin. J Virol (2006) 1.09

Mechanisms of action of DNA-damaging anticancer drugs in treatment of carcinomas: is acute apoptosis an "off-target" effect? Mini Rev Med Chem (2007) 1.09

Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data. Cancer Chemother Pharmacol (2009) 1.08

Minicollagen-15, a novel minicollagen isolated from Hydra, forms tubule structures in nematocysts. J Mol Biol (2007) 1.08

Optical characterization of photonic crystal slabs using orthogonally oriented polarization filters. Opt Express (2008) 1.08

BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells. Int J Cancer (2011) 1.08

Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram. Int J Cancer (2006) 1.07

Clinical cancer proteomics: promises and pitfalls. J Proteome Res (2005) 1.07

Proteasome deubiquitinases as novel targets for cancer therapy. Int J Biochem Cell Biol (2012) 1.07

Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system. Exp Cell Res (2012) 1.06

Structure of zinc-independent sorbitol dehydrogenase from Rhodobacter sphaeroides at 2.4 A resolution. Acta Crystallogr D Biol Crystallogr (2005) 1.05

ERK5 and the regulation of endothelial cell function. Biochem Soc Trans (2009) 1.05

Prevalence of oral human papillomavirus infection among youth, Sweden. Emerg Infect Dis (2012) 1.03

Evolution of glycosaminoglycans: Comparative biochemical study. Commun Integr Biol (2011) 1.02

Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer. Cancer Med (2012) 1.02

The use of coiled-coil proteins in drug delivery systems. Eur J Pharmacol (2009) 1.01

Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells. Biochem Biophys Res Commun (2013) 1.01